← All indications
Lymphoma, Primary Cutaneous Anaplastic Large Cell
Anaplastic lymphoma of the skin which develops as a primary neoplasm expressing the CD30 ANTIGEN. It is characterized by solitary nodules or ulcerated tumors.
Drugs by status
Phase 3 trials (14)
Phase 2 trials (55)
- 23-valent pneumococcal polysaccharide vaccine
- vitamin d3
- acalabrutinib
- allogeneic natural killer cells
- apolizumab
- urea
- busulfan
- lenalidomide
- temsirolimus
- polatuzumab vedotin
- duvelisib
- entospletinib
- n-(4-hydroxyphenyl)all-trans retinamide
- tacrolimus
- beclomethasone
- idelalisib
- Filgrastim
- nivolumab
- pembrolizumab
- ms-553
- ofatumumab
- ibrutinib
- mirdametinib
- pentostatin
- pneumococcal 13-valent conjugate vaccine
- carmustine
- allogeneic hematopoietic stem cells
- sirolimus
- cyclosporine
- mycophenolate
- +25 more
Phase 1 trials (80)
- fau
- decitabine
- azacitidine
- ibritumomab tiuxetan
- afatinib
- alvespimycin
- plerixafor
- olaparib
- sorafenib
- belinostat
- blinatumomab
- irinotecan
- cilengitide
- entinostat
- enzalutamide
- folic acid
- gemcitabine
- oblimersen sodium
- fluorouracil
- paclitaxel
- imatinib
- trametinib
- ar-42
- aldesleukin
- cyanocobalamin
- ispinesib
- lenvatinib
- leucovorin
- me-401
- alisertib
- +50 more
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (1)